Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Ohta

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|April 12, 2016
A Metabolic Immune Checkpoint: Adenosine in Tumor MicroenvironmentAkio Ohta
International Immunology|May 31, 2018
Oxygen-dependent regulation of immune checkpoint mechanismsAkio Ohta
Current Opinion in Pharmacology|June 23, 2009
The adenosinergic immunomodulatory drugsAkio Ohta, Michail Sitkovsky
Journal of Molecular Medicine (Berlin, Germany)|January 22, 2013
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancerMichail Sitkovsky, Akio Ohta
Frontiers in Immunology|July 30, 2014
Extracellular adenosine-mediated modulation of regulatory T cellsAkio Ohta, Michail Sitkovsky
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[Biguanide]Akio Ohta, Yasushi Tanaka
Handbook of Experimental Pharmacology|September 23, 2010
Methylxanthines, inflammation, and cancer: fundamental mechanismsAkio Ohta, Michail Sitkovsky
Trends in Immunology|June 1, 2005
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?Michail V Sitkovsky, Akio Ohta
Journal of Oleo Science|March 24, 2011
Aqueous solution behavior of cationic surfactants containing sulfide linked alkyl chainTsuyoshi Asakawa, Syunsuke Mochizuki, Akio Ohta
Purinergic Signalling|April 12, 2008
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapyDmitriy Lukashev, Michail Sitkovsky, Akio Ohta
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|April 12, 2016
A Metabolic Immune Checkpoint: Adenosine in Tumor MicroenvironmentAkio Ohta
International Immunology|May 31, 2018
Oxygen-dependent regulation of immune checkpoint mechanismsAkio Ohta
Current Opinion in Pharmacology|June 23, 2009
The adenosinergic immunomodulatory drugsAkio Ohta, Michail Sitkovsky
Journal of Molecular Medicine (Berlin, Germany)|January 22, 2013
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancerMichail Sitkovsky, Akio Ohta
Frontiers in Immunology|July 30, 2014
Extracellular adenosine-mediated modulation of regulatory T cellsAkio Ohta, Michail Sitkovsky
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[Biguanide]Akio Ohta, Yasushi Tanaka
Handbook of Experimental Pharmacology|September 23, 2010
Methylxanthines, inflammation, and cancer: fundamental mechanismsAkio Ohta, Michail Sitkovsky
Trends in Immunology|June 1, 2005
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?Michail V Sitkovsky, Akio Ohta
Journal of Oleo Science|March 24, 2011
Aqueous solution behavior of cationic surfactants containing sulfide linked alkyl chainTsuyoshi Asakawa, Syunsuke Mochizuki, Akio Ohta
Purinergic Signalling|April 12, 2008
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapyDmitriy Lukashev, Michail Sitkovsky, Akio Ohta
Pageof 12